de Boer NK - Search Results

1

6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.

de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, Ochsenkühn T, Petritsch W, Knoflach P, Almer S, van der Merwe SW, Herrlinger KR, Seiderer J, Vogelsang H, Mulder CJ; Dutch 6-TG working group. de Boer NK, et al. Digestion. 2006;73(1):25-31. doi: 10.1159/000091662. Epub 2006 Feb 21. Digestion. 2006. PMID: 16493198 Free article. Review.

2

Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.

de Boer NK, van Nieuwkerk CM, Aparicio Pages MN, de Boer SY, Derijks LJ, Mulder CJ. de Boer NK, et al. Among authors: de boer sy. Eur J Gastroenterol Hepatol. 2005 Apr;17(4):457-61. doi: 10.1097/00042737-200504000-00012. Eur J Gastroenterol Hepatol. 2005. PMID: 15756101 Review.

3

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.

Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR. Al Hadithy AF, et al. Among authors: de boer nk. Dig Liver Dis. 2005 Apr;37(4):282-97. doi: 10.1016/j.dld.2004.09.029. Dig Liver Dis. 2005. PMID: 15788214 Review.

4

On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.

de Boer NK, de Graaf P, Wilhelm AJ, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Among authors: de graaf p. Aliment Pharmacol Ther. 2005 Sep 1;22(5):447-51. doi: 10.1111/j.1365-2036.2005.02581.x. Aliment Pharmacol Ther. 2005. PMID: 16128683 Free article.

5

Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity.

de Boer NK, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Liver Transpl. 2005 Oct;11(10):1300-1. doi: 10.1002/lt.20554. Liver Transpl. 2005. PMID: 16184561 Free article. No abstract available.

6

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.

de Boer NK, Derijks LJ, Gilissen LP, Hommes DW, Engels LG, de-Boer SY, den Hartog G, Hooymans PM, Mäkelburg AB, Westerveld BD, Naber AH, Mulder CJ, de Jong DJ. de Boer NK, et al. Among authors: de boer sy, de jong dj. World J Gastroenterol. 2005 Sep 21;11(35):5540-4. doi: 10.3748/wjg.v11.i35.5540. World J Gastroenterol. 2005. PMID: 16222751 Free PMC article.

7

6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child.

de Boer NK, Van Elburg RM, Wilhelm AJ, Remmink AJ, Van Vugt JM, Mulder CJ, Van Bodegraven AA. de Boer NK, et al. Scand J Gastroenterol. 2005 Nov;40(11):1374-7. doi: 10.1080/00365520510024089. Scand J Gastroenterol. 2005. PMID: 16334449

8

Myelotoxicity and hepatotoxicity during azathioprine therapy.

de Boer NK, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Neth J Med. 2005 Dec;63(11):444-6. Neth J Med. 2005. PMID: 16397313 Free article.

9

Impracticalities of thiopurine S-methyltransferase determination in daily inflammatory bowel disease practice.

de Boer NK, Mulder CJ, van Bodegraven AA. de Boer NK, et al. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1278-9; author reply 1279-80. doi: 10.1111/j.1365-2036.2006.02831.x. Aliment Pharmacol Ther. 2006. PMID: 16611294 Free article. No abstract available.

10

Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.

de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. de Boer NK, et al. Among authors: de graaf p. Am J Gastroenterol. 2006 Jun;101(6):1390-2. doi: 10.1111/j.1572-0241.2006.00538.x. Am J Gastroenterol. 2006. PMID: 16771965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters